Orangekloud Technology Inc. (ORKT)
ORKT trades on Nasdaq in Technology, Computer Software: Prepackaged Software. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$0.9408
+0.09% on the day
Market cap
$5.5M
Nano cap
Revenue · 2025
$4.4M
+49.3% on 2024
Net income · 2025
-$3.5M
-78.7% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | ORKT on Nasdaq |
| Sector | Technology |
| Industry | Computer Software: Prepackaged Software |
| Country | Singapore |
| IPO year | 2024 |
| SEC CIK | 0001979407 |
| SEC industry code | Services-Prepackaged Software |
| Incorporated in | E9 |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $4.4M |
| Net income | -$3.5M |
| Operating income | -$5.8M |
| Net margin | -78.7% |
| Operating margin | -131.4% |
| Revenue growth | +49.3% |
| Cash | $2.3M |
| Total assets | $9.2M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 1.2× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B3 | 2024-09-19 |
| Latest annual report | 20-F | 2026-04-30 |
| Latest quarterly / interim | 6-K | 2026-08-24 |
Source: SEC EDGAR submissions feed, 87 recent filings. All filings on EDGAR.
Peers in Computer Software: Prepackaged Software
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| CYAB | Cyabra Inc. | $0.1598 | -4.31% | $5.6M |
| AMST | Amesite Inc. | $0.8500 | +2.40% | $5.6M |
| DFSC | DEFSEC Technologies Inc. | $0.8250 | -2.94% | $5.4M |
| AUID | authID Inc. | $0.3240 | +0.47% | $5.4M |
| MNDR | Mobile-health Network Solutions | $1.46 | -51.97% | $5.4M |
| GXAI | Gaxos.ai Inc. | $0.4801 | +7.50% | $5.3M |
| BKYI | BIO-key International Inc. | $2.83 | +71.52% | $5.8M |
| LHSW | Lianhe Sowell International Group Ltd | $0.4690 | -0.26% | $5.1M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier